Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 42,466 | 50,353 | 34,212 | 35,131 | 36,538 |
| Cost of Goods | 5,467 | 6,016 | 4,009 | 4,528 | 4,195 |
| Gross Profit | 36,999 | 44,337 | 30,203 | 30,603 | 32,343 |
| Operating Expenses | 32,822 | 33,732 | 23,778 | 20,340 | 20,979 |
| Operating Income | 4,644 | 10,621 | 6,434 | 10,791 | 11,559 |
| Interest Expense | 1,122 | 1,313 | 2,052 | 2,269 | 2,327 |
| Other Income | -9,116 | -730 | 2 | -95 | 545 |
| Pre-tax Income | -5,594 | 8,578 | 4,384 | 8,427 | 9,777 |
| Income Tax | -2,110 | -79,975 | 210 | 593 | 713 |
| Net Income Continuous | -3,484 | 88,553 | 4,174 | 7,834 | 9,064 |
| Net Income | $-3,484 | $88,553 | $4,174 | $7,834 | $9,064 |
| EPS Basic Total Ops | -0.07 | 1.87 | 0.09 | 0.17 | 0.20 |
| EPS Basic Continuous Ops | -0.07 | 1.88 | 0.09 | 0.17 | 0.20 |
| EPS Diluted Total Ops | -0.07 | 1.59 | 0.08 | 0.16 | 0.20 |
| EPS Diluted Continuous Ops | -0.07 | 1.57 | 0.07 | 0.16 | 0.20 |
| EPS Diluted Before Non-Recurring Items | -0.07 | 1.34 | 0.08 | N/A | N/A |
| EBITDA(a) | $11,275 | $19,160 | $14,684 | $18,975 | $20,286 |